Back

Roundtable: learnings in practice

27 August 2018 (19:10 - 19:35)
Organised by:
Congress Presentation Part of: Identifying patients who may benefit most from PCSK9i: highlights from the latest ODYSSEY OUTCOMES data Lipids Open Access ESC Congress 2018

About the speakers

Photo
Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)

Photo
Professor Andreas Michael Zeiher

Institute of Cardiovascular Regeneration, Frankfurt (Germany)

6 More presentations in this session

Presentation thumbnail
Welcome and introduction - Highlights from the latest ODYSSEY OUTCOMES data
Professor A. Zeiher (Frankfurt, DE)
Slides Video
Presentation thumbnail
Learnings from the latest PCSK9i results and profiles of patients who may benefit the most: post- ACS patients with elevated atherogenic lipid levels
Professor P. Steg (Paris, FR)
Slides Video
Presentation thumbnail
Learnings from the latest PCSK9i results and and profiles of patients who may benefit the most: efficacy and safety of alirocumab in ODYSSEY OUTCOMES patients with diabetes
Professor K. Ray (London, GB)
Slides Video
Presentation thumbnail
Learnings from the latest PCSK9i results and profiles of patients who may benefit the most: a comprehensive review of the latest lipid lowering therapies outcomes data
Professor C. Cannon (Boston, US)
Slides Video
Presentation thumbnail
Clinical implications for post-ACS patients
Doctor S. Goodman (Toronto, CA)
Slides Video

Access the full session

Session thumbnail
Identifying patients who may benefit most from PCSK9i: highlights from the latest ODYSSEY OUTCOMES data

The Event

Event poster

ESC Congress 2018

27 August 2018 19:10 CET
You may be interested in
thumbnail
Congress Session
Closing the evidence-to-practice gap in cardiovascular pharmacotherapy: where are we still failing?
30 August 2025
thumbnail
Congress Session
Novel mechanisms for insights into atherosclerosis
26 August 2023
thumbnail
Congress Session
What’s on the horizon in heart failure: precision medicine and tailored treatment
18 May 2025
thumbnail
Congress Presentation
Charting the future: panel discussion and Q&A
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources